Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

3461-3470 of 4090 results

Catalogue Number:

PX-TA1138

Category:

G

Proteo Genix logo

Metelimumab Biosimilar – Anti-TGFB1 mAb – Research Grade

Target: TGFB1
Target Alias Name: Metelimumab/CAT-192/TGFB1/anti-TGFB1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2069

Category:

G

Proteo Genix logo

Mevonlerbart Biosimilar – Anti-Allergen FdI mAb – Research Grade

Target: Allergen FdI
Target Alias Name: anti-Allergen FdI/ Major allergen I polypeptide chain 1/ AG4/ Allergen Cat-1/ Allergen Fel d I-A/ Allergen Fel dI/ Fel d 1-A/ CH1/ Major allergen I polypeptide chain 2/ AG4/ Allergen Cat-1/ Allergen Fel d I-B/ Allergen FdI/ Fel d 1-B/ CH2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1543

Category:

G

Proteo Genix logo

Mezagitamab Biosimilar – Anti-CD38 mAb – Research Grade

Target: CD38
Target Alias Name: Mezagitamab /TAK-079/CD38 /anti-CD38
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1684

Category:

G

Proteo Genix logo

Mibavademab Biosimilar – Anti-LEPR mAb – Research Grade

Target: LEPR
Target Alias Name: Mibavademab/IMMUNOGLOBULIN G4 (227-PROLINE)/ ANTI-(HUMAN LEPTIN RECEPTOR) (HUMAN MONOCLONAL REGN4461 .GAMMA.4-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL REGN4461 .KAPPA.-CHAIN/ DIMER/ REGN4461/ REGN-4461/LEPR/anti-LEPR
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1095

Category:

G

Proteo Genix logo

Milatuzumab Biosimilar – Anti-CD74 mAb – Research Grade

Target: CD74
Target Alias Name: Milatuzumab/CD74-DOX (ADC)/MEDI-115/hLL1/hLL1-DOX (ADC)/CD74/anti-CD74
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1221

Category:

G

Proteo Genix logo

Minretumomab Biosimilar – Anti-TAG-72 mAb – Research Grade

Target: TAG-72
Target Alias Name: Minretumomab/Mab CC-49/TAG-72/anti-TAG-72
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1685

Category:

G

Proteo Genix logo

Mipasetamab Biosimilar – Anti-AXL mAb – Research Grade

Target: AXL
Target Alias Name: Mipasetamab/ IMMUNOGLOBULIN G1-KAPPA/ ANTI-(HOMO SAPIENS AXL (AXL RECEPTOR TYROSINE KINASE/ TYROSINE-PROTEIN KINASE RECEPTOR UFO))/ HUMANIZED MONOCLONAL ANTIBODY (MIPASETAMAB)//AXL/anti-AXL
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1686

Category:

G

Proteo Genix logo

Miptenalimab Biosimilar – Anti-LAG3 mAb – Research Grade

Target: LAG3
Target Alias Name: Miptenalimab/BI754111/BI-754111/ IMMUNOGLOBULIN G4 (230-PROLINE)/ ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3) (HUMAN MONOCLONAL BI754111 .GAMMA.4-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL BI754111 .KAPPA.-CHAIN/ DIMER/LAG3/anti-LAG3
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1489

Category:

G

Proteo Genix logo

Mirikizumab Biosimilar – Anti-IL23A mAb – Research Grade

Target: IL23A
Target Alias Name: Mirikizumab/LY-3074828/IL23A/anti-IL23A
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1687

Category:

G

Proteo Genix logo

Miromavimab Biosimilar – Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II mAb – Research Grade

Target: Rabies Virus Strain ERA GP Ectodomain Epitope G-II
Target Alias Name: Miromavimab/IMMUNOGLOBULIN G1/ ANTI-(RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-II) (MUS MUSCULUS MONOCLONAL M777-16-3 .GAMMA.1-CHAIN)/ DISULFIDE WITH MUS MUSCULUS MONOCLONAL M777-16-3 .KAPPA.-CHAIN/ DIMER/Rabies Virus Strain ERA GP Ectodomain Epitope G-II/anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo